Orchid Pharma Ltd Half Yearly Results

Gross Sales

467.1

437.69

381.68

369.66

296.24

Excise Duty

0

0

0

0

0

Net Sales

467.1

437.69

381.68

369.66

296.24

Other Operating Income

0

0

0

0

0

Other Income

15.09

20.62

10.24

49.87

8.77

Total Income

482.19

458.31

391.92

419.53

305.01

Total Expenditure

404.27

372.48

336.22

323.09

265.97

PBIDT

77.92

85.84

55.7

96.44

39.04

Interest

6.83

7

9.35

15.16

17.06

PBDT

71.09

78.84

46.35

81.28

21.98

Depreciation

17.07

17.69

15.55

15.39

39.39

Minority Interest Before NP

0

0

0

0

0

Tax

-0.15

0.11

0

0

0

Deferred Tax

0

-3.23

0

0

0

Reported Profit After Tax

54.17

64.27

30.8

65.88

-17.41

Minority Interest After NP

0

0

0

0

0

Net Profit after Minority Interest

56.59

62.96

29.21

66.73

-20.41

Extra-ordinary Items

0

0

0

32.44

0

Adjusted Profit After Extra-ordinary item

56.59

62.96

29.21

34.29

-20.41

EPS (Unit Curr.)

11.16

12.41

6.35

16.35

-5

Book Value (Unit Curr.)

0

0

0

0

0

Dividend (%)

0

0

0

0

0

Equity

50.72

50.72

50.72

40.82

40.82

Public Shareholding (Number)

0

0

0

0

0

Public Shareholding (%)

0

0

0

0

0

Pledged/Encumbered - No. of Shares

0

0

0

0

0

Pledged/Encumbered - % in Total Promoters Holding

0

0

0

0

0

Pledged/Encumbered - % in Total Equity

0

0

0

0

0

Non Encumbered - No. of Shares

0

0

0

0

0

Non Encumbered - % in Total Promoters Holding

0

0

0

0

0

Non Encumbered - % in Total Equity

0

0

0

0

0

PBIDTM(%)

16.68

19.61

14.59

26.08

13.17

PBDTM(%)

-

-

-

-

-

PATM(%)

11.59

14.68

8.06

17.82

-5.87